GLP-1 / Metabolic

Tesofensine

Also known as: NS2330

Tesofensine is a small-molecule triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) — NOT a peptide. Originally developed by NeuroSearch for Parkinson's and Alzheimer's disease (which it failed to benefit) and repositioned for obesity by Saniona. Not FDA-approved in the US.

Vendors carrying Tesofensine

0 listings, ranked by trust score

Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.

No vendors carrying this peptide are indexed yet.